Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice

Neurotoxicology and Teratology

Volumn 31, Issue 1, 2009, Pages 49-59

  Daza Losada, M ^a   Rodriguez Arias M ^a   Maldonado, C ^a   Aguilar, M A ^a   Guerri, C ^b   Minarro J ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

Cocaine; Dopamine; Elevated plus maze; MDMA; Mice; Serotonin; Social behaviour

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BRAIN MONOAMINE; COCAINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; HYPERACTIVITY; MALE; MOTOR ACTIVITY; MOUSE; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CEREBRAL CORTEX; COCAINE; HIPPOCAMPUS; INTERPERSONAL RELATIONS; MALE; MICE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEOSTRIATUM; NEUROTOXICITY SYNDROMES; SEROTONIN AGENTS;

ANIMALIA; MUS;

EID: 57249115876     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.07.005     Document Type: Article

References (79)

1. Åberg M., Wade D., Wall E., and Izenwasser S. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicol. Teratol. 29 (2007) 37-46
2. Achat-Mendes C., Anderson K.L., and Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology, 45 (2003) 106-115
3. Aguilar M.A., Miñarro J., and Felipo V. Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp. Neurol. 161 (2000) 704-713
4. Balogh B., Molnar E., Jakus R., Quate L., Olverman H.J., Kelly P.A., Kantor S., and Bagdy G. Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology 173 (2004) 296-309
5. Bankson M.G., and Cunningham K.A. Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors. Neuropsychopharmacology 26 (2002) 40-52
6. Barrionuevo M., Aguirre N., Del Río J.D., and Lasheras B. Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA. Pharmacol. Biochem. Behav. 65 (2000) 233-240
7. Battaglia G., Yeh S.Y., and De Souza E.B. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol. Biochem. Behav. 29 (1988) 269-274
8. Baylen C.A., and Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101 (2006) 933-947
9. Bhattacharya S.K., Bhattacharya A., and Ghosal S. Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): an experimental study. Biog. Amines 14 (1998) 217-237
10. Bolla K.I., McCann U.D., and Ricaurte G.A. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 51 (1998) 1532-1537
11. Brain P.F., Benton D., Childs G., and Parmigiani S. The effect of the type of opponent in test of murine aggression. Behav. Process 6 (1981) 319-327
12. Brain P.F., McAllister K.H., and Walmsley S.V. Drug effects on social behaviours. In: Boulton A.A., Bake G.B., and Greenshaw A.J. (Eds). Methods in Ethopharmacology, Psychopharmacology (1989), The Humana Press Inc., Clifton NJ 687-739
13. Bull E.J., Hutson P.H., and Fone K.C. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity. Neuropharmacology 44 (2003) 439-448
14. Bull E.J., Hutson P.H., and Fone K.C. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity. Neuropharmacology 46 (2004) 202-210
15. Colado M.I., O'Shea E., and Green A.R. Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173 (2004) 249-263
16. Compas B.E., Hinden B.R., and Gerhardt C.A. Adolescent development: pathways and processes of risk and resilience. Annu. Rev. Psychol. 46 (1995) 265-293
17. Cornish J.L., Shahnawaz Z., Thompson M.R., Wong S., Morley K.C., Hunt G.E., and McGregor I.S. Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur. J. Pharmacol. 482 (2003) 339-341
18. Daza-Losada M., Ribeiro Do Couto B., Manzanedo C., Aguilar M.A., Rodríguez-Arias M., and Miñarro J. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 32 (2007) 1750-1759
19. Diller A.J., Rocha A., Cardon A.L., Valles R., Wellman P.J., and Nation J.R. The effects of concurrent administration of +/-3,4-methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat. Pharmacol. Biochem. Behav. 88 (2007) 165-170
20. Erhardt E., Zibetti L.C., Godinho J.M., Bacchieri B., and Barros H.M. Behavioral changes induced by cocaine in mice are modified by a hyperlipidic diet or recombinant leptin. Braz. J. Med. Biol. Res. 39 (2006) 1625-1635
21. Escobedo I., O'Shea E., Orio L., Sanchez V., Segura M., de la Torre R., Farre M., Green A.R., and Colado M.I. A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice. Br. J. Pharmacol. 144 (2005) 231-241
22. Estelles J., Rodriguez-Arias M., Aguilar M.A., and Minarro J. Social behavioural profile of cocaine in isolated and grouped male mice. Drug Alcohol Depend. 76 (2004) 115-123
23. Estelles J., Rodriguez-Arias M., Maldonado C., Aguilar M.A., and Minarro J. Prenatal cocaine exposure alters spontaneous and cocaine-induced motor and social behaviors. Neurotoxicol. Teratol. 27 (2005) 449-457
24. Estelles J., Lluch J., Rodríguez-Arias M., Aguilar M.A., and Miñarro J. Cocaine exposure during adolescence affects anxiety in adult mice. Brain Res. Bull. 71 (2007) 393-403
25. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
26. Gudelsky G.A., and Yamamoto B.K. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopamineric, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 90 (2008) 198-207
27. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 3 (2006) 6:6
28. Heffner T.G., Hartman J.A., and Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13 (1980) 453-456
29. Hefner K., and Holmes A. Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice. Behav. Brain Res. 176 (2007) 210-215
30. Ho Y.J., Pawlak C.R., Guo L., and Schwarting R.K. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav. Brain Res. 149 (2004) 135-144
31. Horan B., Gardner E.L., and Ashby Jr. C.R. Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA). Synapse 35 (2000) 160-162
32. Itzhak Y., and Ali S.F. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol. Ther. 109 (2006) 246-262
33. Koenig J., Lazarus C., Jeltsch H., Ben Hamida S., Riegert C., Kelche C., Jones B.C., and Cassel J.C. MDMA (ecstasy) effects in pubescent rats: males are more sensitive than females. Pharmacol. Biochem. Behav. 81 (2005) 635-644
34. Laviola G., Adriani W., Terranova M.L., and Gerra G. Psychobiological risk factors for vulnerability to psychostimulants in human adolescents and animal models. Neurosci. Biobehav. Rev. 23 (1999) 993-1010
35. Lin H.Q., Burden P.M., Christie M.J., and Johnston G.A. The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine. Pharmacol. Biochem. Behav. 62 (1999) 403-408
36. Lluch J., Rodriguez-Arias M., Aguilar M.A., and Minarro J. Role of dopamine and glutamate receptors in cocaine-induced social effects in isolated and grouped male OF1 mice. Pharmacol. Biochem. Behav. 82 (2005) 478-487
37. Logan B.J., Laverty R., Sanderson W.D., and Yee Y.B. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur. J. Pharmacol. 152 (1988) 227-234
38. Maldonado C., Rodríguez-Arias M., Castillo A., Aguilar M.A., and Miñarro J. Gamma-hydroxybutyric acid affects the acquisition and reinstatement of cocaine-induced conditioned place preference in mice. Behav. Pharmacol. 17 (2006) 119-131
39. Maldonado E., and Navarro J.F. MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice. Pharmacol. Res. 44 (2001) 27-31
40. McCann U.D., and Ricaurte G.A. MDMA ("ecstasy") and panic disorder: induction by a single dose. Biol. Psychiatry 32 (1992) 950-953
41. McNamara M.G., Kelly J.P., and Leonard B.E. Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats. Pharmacol. Biochem. Behav. 52 (1995) 479-484
42. Montgomery C., Fisk J.E., Newcombe R., and Murphy P.N. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology 182 (2005) 262-276
43. Morgan M.J. Memory deficits associated with recreational use of "ecstasy". Psychopharmacology 141 (1999) 30-36
44. Morley K.C., and McGregor I.S. (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Eur. J. Pharmacol. 408 (2000) 41-49
45. Morley K.C., Arnold J.C., and McGregor I.S. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 648-657
46. Morley-Fletcher S., Bianchi M., Gerra G., and Laviola G. Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence. Eur. J. Pharmacol. 448 (2002) 31-38
47. Moyano S., Frechilla D., and Del Río J. NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment. Psychopharmacology 173 (2004) 337-345
48. Moyano S., Del Río J., and Frechilla D. Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits. Pharmacol. Biochem. Behav. 82 (2005) 190-199
49. Mugford R.A., and Nowell N.W. Pheromones and their effect on aggression in mice. Nature 226 (1970) 967-968
50. Navarro J.F., Rivera A., Maldonado E., Cavas M., and de la Calle A. Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 249-254
51. Navarro J.F., and Maldonado E. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 1151-1154
52. O'Callaghan J.P., and Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270 (1994) 741-751
53. O'Shea E., Esteban B., Camarero J., Green A.R., and Colado M.I. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology 40 (2001) 65-74
54. Palenicek T., Votava M., Bubenikova V., and Horacek J. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Physiol. Behav. 86 (2005) 546-553
55. Parrott A.C., Lees A., Garnham N.J., Jones M., and Wesnes K. Cognitive performance in recreational users of MDMA or "ecstasy": evidence for memory deficits. J. Psychopharmacol. 12 (1998) 79-83
56. Parrott A.C., Milani R.M., Parmar R., and Turner J.D. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems. Psychopharmacology 159 (2001) 77-82
57. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24 (1986) 525-529
58. Reay J.L., Hamilton C., Kennedy D.O., and Scholey A.B. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J. Psychopharmacol. 20 (2006) 385-388
59. Reveron M.E., Monks T.J., and Duvauchelle C.L. Age-dependent (+)MDMA-mediated neurotoxicity in mice. Neurotoxicology 26 (2005) 1031-1040
60. Ricaurte G.A., Markowska A.L., L Wenk G., Hatzidimitriou G., Wlos J., and Olton D.S. 3,4-Methylenedioxymethamphetamine, serotonin and memory. J. Pharmacol. Exp. Ther. 266 (1993) 1097-1105
61. Rodgers R.J., Cutler M.G., and Jackson J.E. Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze. Pharmacol. Biochem. Behav. 57 (1997) 127-136
62. Rodgers J. Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 151 (2000) 19-24
63. Rodriguez-Arias M., Minarro J., Aguilar M.A., Pinazo J., and Simon V.M. Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur. Neuropsychopharmacol. 8 (1998) 95-103
64. Rogerio R., and Takahashi R.N. Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze. Pharmacol. Biochem. Behav. 43 (1992) 631-633
65. Santucci A.C., Knott P.J., and Haroutunian V. Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur. J. Pharmacol. 295 (1996) 7-17
66. Schramm-Sapyta N.L., Morris R.W., and Kuhn C.M. Adolescent rats are protected from the conditioned aversive properties of cocaine and lithium chloride. Pharmacol. Biochem. Behav. 84 (2006) 344-352
67. Smoothy R., Brain P.F., Berry M.S., and Haug M. Alcohol and social behaviour in group-housed female mice. Physiol. Behav. 37 (1986) 689-694
68. Solowij N., Hall W., and Lee N. Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. Br. J. Addict. 87 (1992) 1161-1172
69. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 24 (2000) 417-463
70. St Omer V.E., Ali S.F., Holson R.R., Duhart H.M., Scalzo F.M., and Slikker Jr. W. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats. Neurotoxicol. Teratol. 13 (1991) 13-20
71. Terranova M.L., Laviola G., and Alleva E. Ontogeny of amicable social behavior in the mouse: gender differences and ongoing isolation outcomes. Dev. Psychobiol. 26 (1993) 467-481
72. Terranova M.L., Laviola G., de Acetis L., and Alleva E. A description of the ontogeny of mouse agonistic behaviour. J. Comp. Psychol. 112 (1998) 3-12
73. The National Survey on Drug Use and Health. United Nations Office on Drugs and Crime (UNODC) (2005). World drug report, vol. 1: Analysis, Vienna: UNODC (2004)
74. Timár J., Gyarmati S., Szabó A., and Fürst S. Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives. Behav. Pharmacol. 14 (2003) 199-206
75. Uhl J.R., Hall F.S., and Sora I. Cocaine, reward, movement and monoamine transporters. Mol. Psychiatry 7 (2002) 21-26
76. Vollenweider F.X., Gamma A., Liechti M., and Huber T. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers. Neuropsychopharmacology 19 (1998) 241-251
77. Whitaker-Azmitia P.M., and Aronson T.A. "Ecstasy" (MDMA)-induced panic. Am. J. Psychiatry 146 (1989) 119
78. Wish E.D., Fitzelle D.B., O'Grady K.E., Hsu M.H., and Arria A.M. Evidence for significant polydrug use among ecstasy-using college students. J. Am. Coll. Health 55 (2006) 99-104
79. Yang X.M., Gorman A.L., Dunn A.J., and Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies. Pharmacol. Biochem. Behav. 41 (1992) 643-650